A 72-year-old patient with known heart failure with reduced ejection fraction (HFrEF) is admitted with worsening dyspnoea and peripheral oedema. He is...

Question

A 72-year-old patient with known heart failure with reduced ejection fraction (HFrEF) is admitted with worsening dyspnoea and peripheral oedema. He is on a loop diuretic. According to guidelines, which additional medication class offers proven mortality benefit in HFrEF?

Accepted Answer

ACE inhibitors (e.g., ramipril)

Answer

Thiazide diuretic

Answer

Beta-2 agonists

Answer

Digoxin

Answer

Short-acting nitrates

ukmla MCQ (SBA): Heart failure with reduced ejection fraction (HFrEF)

A 72-year-old patient with known heart failure with reduced ejection fraction (HFrEF) is admitted with worsening dyspnoea and peripheral oedema. He is on a loop diuretic. According to guidelines, which additional medication class offers proven mortality benefit in HFrEF?